---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000876"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:39:35.099138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve issuance of up to 20.46M shares in Deerfield convertible notes and warrants

## Summary
- All nine director nominees elected with strong support; broker non-votes of ~12.2M shares.
- Ratification of BDO USA as independent auditor approved: 60.8M for, 192k against, 50k abstain.
- Proposal 3 approved: allows issuance of up to 20,459,040 shares upon conversion of Deerfield convertible notes and exercise of warrants.
- Turnout: 61.08M shares voted (82.06% of outstanding).

## SEC filing metadata
- accession: 0001079973-24-000876
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997324000876/0001079973-24-000876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997324000876/toi_8k-agm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000876
- JSON: https://secwatch.observer/filing/0001079973-24-000876.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000876.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.